World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
19486
World Ranking
2209
National Ranking
1070

Pavan Reddy publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Pavan Reddy sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 330 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Pavan Reddy D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Pavan Reddy sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Pavan Reddy is affiliated with Baylor College of Medicine in the United States. Their research spans several interconnected fields, primarily focusing on medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. With a publication record including over 112 works in medicine and 45 in biochemistry and molecular biology, the scope of their research covers a broad spectrum relevant to healthcare and biological sciences.

The scientist's main subfields of study include immunology, molecular biology, hematology, pulmonary and respiratory medicine, and oncology. Their major research topics further refine this focus, centering around hematopoietic stem cell transplantation, immune cell function and interaction, gut microbiota and health, oral health in cancer treatment, T-cell and B-cell immunology, nutrition and health in aging, and acute lymphoblastic leukemia research.

Their recent publications demonstrate active engagement with topics relevant to immunology, transplantation, and microbiome research:

  • A redox cycle with complex II prioritizes sulfide quinone oxidoreductase-dependent H2S oxidation, 2021, Journal of Biological Chemistry
  • Prevention and Treatment of Acute Graft-versus-Host Disease in Children, Adolescents, and Young Adults, 2020, Biology of Blood and Marrow Transplantation
  • Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment, 2022, Science Translational Medicine
  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report, 2021, Transplantation and Cellular Therapy
  • Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease, 2024, Nature Microbiology

The venues where this scientist frequently publishes indicate consistent contributions to transplantation and hematology research. Leading publication venues include:

  • Transplantation and Cellular Therapy
  • Blood
  • Biology of Blood and Marrow Transplantation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood Advances

Collaboration plays an important role in their research activities. The most frequent coauthors include:

  • Daniel Peltier
  • Katherine Oravecz-Wilson
  • Mary Riwes
  • John Magenau
  • Attaphol Pawarode

This profile reflects a researcher who works extensively on hematopoietic stem cell transplantation and immune system interactions, with a growing focus on how gut microbiota influence health outcomes in contexts such as cancer treatment and graft-versus-host disease. The diversity of research topics and consistent publication pattern across specialized journals underline their active role in advancing biomedical and clinical knowledge.

Best Publications

  • Graft-versus-host disease

    James L M Ferrara;John E Levine;Pavan Reddy;Ernst Holler

  • Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease.

    Nathan D. Mathewson;Robert R Jenq;Anna V. Mathew;Mark Koenigsknecht

  • Acute graft-versus-host disease does not require alloantigen expression on host epithelium

    Takanori Teshima;Rainer Ordemann;Pavan Reddy;Svetlana Gagin

  • Pathophysiology of graft-versus-host disease

    James L.M. Ferrara;Pavan Reddy

  • A biomarker panel for acute graft-versus-host disease

    Sophie Paczesny;Sophie Paczesny;Oleg I Krijanovski;Thomas M Braun;Sung Won Choi

  • ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

    Mark T. Vander Lugt;Thomas M. Braun;Samir Hanash;Jerome Ritz

  • Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

    James L.M. Ferrara;Andrew C. Harris;Joel K. Greenson;Thomas M. Braun

  • Immunobiology of acute graft-versus-host disease.

    Pavan Reddy;James L.M Ferrara

  • Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease

    Ulrich A. Duffner;Yoshinobu Maeda;Kenneth R. Cooke;Pavan Reddy

  • Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect

    Pavan Reddy;Yoshinobu Maeda;Kevin Hotary;Chen Liu

  • Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in mice

    Pavan Reddy;Yaping Sun;Tomomi Toubai;Raimon Duran-Struuck

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin

    Sophie Paczesny;Thomas M. Braun;John E. Levine;Jason Hogan

  • A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses.

    Pavan Reddy;Yoshinobu Maeda;Chen Liu;Oleg I Krijanovski

  • Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.

    Erin Gatza;Clare E. Rogers;Shawn G. Clouthier;Kathleen P. Lowler

  • Current and emerging strategies for the prevention of graft-versus-host disease

    Sung Won Choi;Pavan Reddy

  • Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

    Voravit Ratanatharathorn;Lois Ayash;Christopher Reynolds;Samuel Silver

  • Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis

    Pavan Reddy;Takanori Teshima;Mark Kukuruga;Rainer Ordemann

  • An early-biomarker algorithm predicts lethal graft-versus-host disease and survival

    Matthew J. Hartwell;Umut Özbek;Ernst Holler;Anne S. Renteria

  • Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

    John E. Levine;Sophie Paczesny;Shin Mineishi;Thomas Braun

  • Pathophysiology of acute graft-versus-host disease.

    Pavan Reddy

Frequent Co-Authors

James L.M. Ferrara
James L.M. Ferrara Icahn School of Medicine at Mount Sinai
Chen Liu
Chen Liu Yale University
Sophie Paczesny
Sophie Paczesny Medical University of South Carolina
Takanori Teshima
Takanori Teshima Hokkaido University
Kenneth R. Cooke
Kenneth R. Cooke Johns Hopkins University School of Medicine
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus
Daniel F. Hayes
Daniel F. Hayes University of Michigan–Ann Arbor
Ernst Holler
Ernst Holler University of Regensburg
Samir M. Hanash
Samir M. Hanash The University of Texas MD Anderson Cancer Center
Ivan Maillard
Ivan Maillard University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various specialized healthcare roles, particularly in nursing and advanced practice fields. For those interested in mental health, exploring the best online psychiatric mental health nurse practitioner programs can lead to rewarding careers with strong clinical training and placement opportunities.

Cost is often a major consideration. Students seeking affordable options may find value in the cheapest online pmhnp programs, which provide quality education without compromising financial feasibility.

Advanced degrees such as the Doctor of Nursing Practice (DNP) often correlate with higher earning potential. Understanding how much do dnps make can help guide career decisions based on location and specialization. Immunology graduates interested in critical care might also consider transitioning through acute care nurse practitioner programs to expand their expertise and impact patient outcomes in high-acuity settings.

Overall, integrating immunology knowledge with advanced nursing programs enhances career flexibility and opportunities in the evolving healthcare landscape.

Best Scientists Citing Pavan Reddy

Trending Scientists

Recently Published Articles